EAHAD/LinkedIn
Sep 5, 2025, 14:12
EAHAD Podcast: Reducing Pain and Distress in Children Receiving Emicizumab
EAHAD (The European Association for Haemophilia and Allied Disorders) posted on LinkedIn:
”New Podcast Alert! Join us for the latest “Meet the Author Interview” with Maj Friberg Birkedal, Chair of the EAHAD Nurses Committee, discussing how the Neria Guard infusion set may help reduce pain and distress for children receiving emicizumab. Drawing on real-world experience, she highlights why even small innovations can make a big difference in paediatric care.
Tune in now.”
Stay updated with Hemostasis Today.
-
Feb 11, 2026, 17:00A Major Step Forward for the Global Bleeding Disorders Community – Haemophilia Foundation Australia
-
Feb 11, 2026, 16:47Pall T. Onundarson and Mandeep Mehra on Diverse Approaches to Anticoagulation in LVAD Patients
-
Feb 11, 2026, 16:37Rahul Gosain: Are Cancer Outcomes Directly Related to Lymphocyte Counts?
-
Feb 11, 2026, 16:35Are DOACs Actually Safer in Advanced Cirrhosis – RPTH Journal
-
Feb 11, 2026, 16:33Reza Shojaei: Transforming Canada’s Plasma System for Greater Resilience and Self-Sufficiency
-
Feb 11, 2026, 16:31Pat Garcia-Gonzalez: A Bold Plan to Double Impact and Reach 100,000 Patients by 2031
-
Feb 11, 2026, 16:20Ney Carter Borges։ Clinical Importance of Coronary Microcirculation in MINOCA and INOCA
-
Feb 11, 2026, 16:18The Hidden Risks of Blood Thinners and the Need for Safer Anticoagulants – National Blood Clot Alliance
-
Feb 11, 2026, 16:13Thomas Reiser: A Great Opportunity to Advance the Field of Thrombosis and Hemostasis